HOME >> MEDICINE >> NEWS
Therapy Developed At Cedars-Sinai Medical Center Shows Promise In Preventing Rejection Of Transplanted Organs

A therapeutic approach that appears to significantly reduce the rejection risk of transplanted organs is currently being studied in multi-center clinical trials but already has been adopted as an effective tool by most major transplant centers throughout the country.

The therapy, infusion of intravenous immunoglobulin (IVIG), appears to be helpful in preventing rejection in difficult cases when other medications have failed, according to Stanley C. Jordan, M.D., director of Pediatric Nephrology and Transplant Immunology, and medical director of the Renal Transplant Program at Cedars-Sinai Medical Center.

Led by Dr. Jordan, researchers at Cedars-Sinai Medical Center began to develop the concept of using gammaglobulin in a transplant environment in the late 1980s as IVIG was becoming established as a therapy for immune system disorders. "IVIG treatment has given the gift of life to many patients who would not have had a chance at transplantation or would have died or languished on dialysis without the hope of a life-saving transplant," Dr. Jordan said.

Immunoglobulins are proteins naturally produced within the body that can act as antibodies -- natural defenses against invading organisms called antigens. A processed form of immunoglobulin made from blood plasma can be administered to bolster the body's natural levels. For transplant specialists looking to modify the immune system so that it will accept the "foreign tissue" of a transplanted organ, IVIG products possess several appealing properties.

"We have other very powerful drugs that are currently available to suppress the immune system but there is a price to pay. They make the patient more susceptible to infectious complications because most of the medications are globally immunosuppressive," said Dr. Jordan. "The good thing about IV gammaglobulin therapy is that it modulates the immune system, it doesn't suppress it, and it doesn't predispose the patient to infectious complications. We think
'"/>

Contact: Sandra Van
Sandy@VanCommunications.com
1-800-396-1002
Cedars-Sinai Medical Center
5-May-1999


Page: 1 2 3 4 5

Related medicine news :

1. UT Southwestern Moncrief Cancer Center is first in Texas to treat patients with TomoTherapy
2. Therapy, medication combination superior for children with obsessive-compulsive disorder
3. Oncology Nursing Society honors Fox Chase Cancer Center nurse with Radiation Therapy Nursing Award
4. Therapy for mice with prion disease could offer benefit to human beings with CJD
5. Vagus Nerve Stimulation Therapy (TM) more effective in epilepsy patients when used earlier
6. Therapy to help women reduce their concerns about gaining weight found to be effective in helping them to stop smoking
7. Results of NUVANCE (IL-4 receptor) in Phase I/II study in asthma patients featured at AAAAI Late-Breaker Abstract and Asthma Therapy Sessions
8. UCSF Study Shows That An Herbal Therapy Reduces PSA Levels By Half In Men With Advanced Prostate Cancer
9. Sniffing Out The Promise Of Anti-Angiogenesis Therapy
10. Breakthrough New Therapy Uses Antibody-Targeted Chemotherapy To Fight Leukemia
11. Jefferson Researchers Report First Evidence Of Radiation Therapy Preventing Prostate Cancer Patients From Dying

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2019)... ... June 14, 2019 , ... ... Security solutions, today announced it has received the coveted “2019 Best DLP Solution ... that Works Platform along with the latest additions to its Data Security Portfolio ...
(Date:6/14/2019)... , ... June 14, 2019 , ... ... Tempur-Pedic® Mattress & Pink Bag Event® scheduled for Saturday, July 13th. UBCF is ... men and children directly impacted by breast cancer. This second event was added ...
(Date:6/13/2019)... ... June 13, 2019 , ... MMJ BioPharma Cultivation, a premier ... memorandum of understanding (MOU) with MMJ International Holdings to grow cannabis and supply ... BioPharma Cultivation will be supplying MMJIH with extracts from the marijuana plant to ...
(Date:6/13/2019)... ... June 13, 2019 , ... Pure Ratios, the ... cannabis delivery company, Driven Deliveries, Inc., the only publicly traded cannabis delivery service ... the population of California with overnight cannabis delivery to major thriving markets such ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... everyone in healthcare, today announced that Jon Elwell, the company’s CEO, has been ... DirectTrust is a non-profit health care industry alliance created to support ...
Breaking Medicine News(10 mins):
(Date:6/13/2019)... ... June 13, 2019 , ... Homecare Homebase ... the new Smart Scheduling product, part of the HCHB Intelligence Suite, at the ... uses complex algorithms to create highly efficient routing, mapping and scheduling for home ...
(Date:6/13/2019)... ... 13, 2019 , ... Access Healthcare , a leading provider of healthcare ... at the HFMA Annual Conference 2019 which will be held on June ... Access Healthcare, says, “HFMA Annual Conference has inspired us in many ways – right ...
(Date:6/13/2019)... ... , ... RxNT announced today that it has been named by ... RxNT is a leader in healthcare technology solutions. This is the fourth time RxNT ... highlight the best software products from North American small businesses. RxNT won the FrontRunner ...
Breaking Medicine Technology:
Cached News: